|
US4036842A
(en)
|
1972-05-16 |
1977-07-19 |
American Home Products Corporation |
Process for preparing polycyclic heterocycles having a pyran ring
|
|
US4021451A
(en)
|
1972-05-16 |
1977-05-03 |
American Home Products Corporation |
Process for preparing polycyclic heterocycles having a pyran ring
|
|
US4021452A
(en)
|
1975-04-23 |
1977-05-03 |
American Cyanamid Company |
2,5-Dihydro-2,5-dialkoxyfuran derivatives
|
|
US4127665A
(en)
|
1978-01-18 |
1978-11-28 |
Pfizer Inc. |
Thienohydantoin derivatives
|
|
FR2459239A1
(fr)
|
1979-06-20 |
1981-01-09 |
Logeais Labor Jacques |
Nouveaux derives amines du benzothiazole, leur procede de preparation et leur application en therapeutique
|
|
PH30676A
(en)
|
1986-07-22 |
1997-09-16 |
Boehringer Ingelhein Kg |
Hetrazepine compounds which have useful pharmaceutical utility
|
|
CA1336909C
(en)
|
1988-03-16 |
1995-09-05 |
Vittorio Vecchietti |
Heterocyclic derivatives
|
|
DE3827727A1
(de)
|
1988-08-16 |
1990-02-22 |
Boehringer Ingelheim Kg |
Anellierte tetrahydropyridinessigsaeurederivate, verfahren zu deren herstellung und verwendung solcher verbindungen zur kardioprotektion
|
|
GB8824400D0
(en)
|
1988-10-18 |
1988-11-23 |
Glaxo Group Ltd |
Chemical compounds
|
|
EP0368175A1
(de)
|
1988-11-06 |
1990-05-16 |
Boehringer Ingelheim Kg |
3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
|
|
GB8827479D0
(en)
|
1988-11-24 |
1988-12-29 |
Zambeletti Spa L |
Novel compounds
|
|
EP0416740A3
(en)
|
1989-08-08 |
1991-08-28 |
Beecham Group P.L.C. |
Novel compounds with renin-inhibiting activity
|
|
GB8926560D0
(en)
|
1989-11-24 |
1990-01-17 |
Zambeletti Spa L |
Pharmaceuticals
|
|
US5032598A
(en)
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
|
|
GB8927872D0
(en)
|
1989-12-08 |
1990-02-14 |
Beecham Group Plc |
Pharmaceuticals
|
|
ZA912744B
(en)
|
1990-03-23 |
1992-02-26 |
Zambeletti Spa L |
Pharmaceuticals
|
|
JPH049367A
(ja)
|
1990-04-26 |
1992-01-14 |
Zeria Pharmaceut Co Ltd |
アリールアルカノイル誘導体，該化合物の製造中間体及びそれらを含有する医薬
|
|
GB9018139D0
(en)
|
1990-08-17 |
1990-10-03 |
Pfizer Ltd |
Therapeutic agents
|
|
NZ240155A
(en)
|
1990-10-29 |
1992-10-28 |
Ishihara Sangyo Kaisha |
Heterocyclyl acyl and (hexahydro) indanyl acyl substituted hydrazine derivatives, preparation thereof and pesticidal compositions
|
|
DE4104257A1
(de)
|
1991-02-13 |
1992-08-20 |
Boehringer Ingelheim Kg |
Verwendung von anellierten tetrahydropyridinessigsaeurederivaten fuer die behandlung neurologischer erkrankungen
|
|
GB9104839D0
(en)
|
1991-03-07 |
1991-04-17 |
Zambeletti Spa L |
Novel compounds
|
|
NZ243065A
(en)
|
1991-06-13 |
1995-07-26 |
Lundbeck & Co As H |
Piperidine derivatives and pharmaceutical compositions
|
|
PH31294A
(en)
|
1992-02-13 |
1998-07-06 |
Thomae Gmbh Dr K |
Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them.
|
|
JP3223277B2
(ja)
|
1992-04-10 |
2001-10-29 |
カシオ計算機株式会社 |
楽音制御装置
|
|
FR2692264B1
(fr)
|
1992-06-12 |
1994-08-05 |
Adir |
Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
|
|
IT1255178B
(it)
|
1992-06-26 |
1995-10-20 |
Pierrel Spa |
N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica
|
|
EP0600836B1
(de)
|
1992-12-02 |
1998-08-05 |
Novartis AG |
Selektiv-herbizides Mittel
|
|
TW334423B
(en)
|
1993-10-22 |
1998-06-21 |
Hoffmann La Roche |
Tricyclic 1-aminoethylpyrrole-derivatives
|
|
JP3163068B2
(ja)
|
1993-12-27 |
2001-05-08 |
日本建工株式会社 |
野縁取付け金具
|
|
FR2723091B1
(fr)
|
1994-07-29 |
1996-11-08 |
Esteve Labor Dr |
Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
|
|
FR2734819B1
(fr)
|
1995-05-31 |
1997-07-04 |
Adir |
Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
|
|
HUP0104984A3
(en)
|
1998-03-12 |
2003-07-28 |
Ontogen Corp Carlsbad |
Modulators of protein tyrosine phosphatases (ptpases) pharmaceutical compositions containing them and their use
|
|
US6262044B1
(en)
|
1998-03-12 |
2001-07-17 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (PTPASES)
|
|
WO1999046237A1
(en)
|
1998-03-12 |
1999-09-16 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases
|
|
WO1999046267A1
(en)
|
1998-03-12 |
1999-09-16 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (ptpases)
|
|
AU6325599A
(en)
|
1998-10-21 |
2000-05-08 |
Dr. Reddy's Research Foundation |
New compounds, their preparation and use
|
|
TR200101649T2
(tr)
|
1998-12-14 |
2001-10-22 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperazin türevleri.
|
|
DE60028538T2
(de)
|
1999-01-19 |
2007-06-21 |
Neurosearch A/S |
Kondensierte heterocyclische verbindungen und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
|
|
US6313309B1
(en)
|
1999-04-05 |
2001-11-06 |
Ortho-Mcneil Pharmaceutical, Inc. |
4-thionaphthyl—1H—imidazoles which are usefulα22-adrenoceptoR agonists/ antagonists
|
|
WO2000068230A1
(en)
|
1999-05-05 |
2000-11-16 |
Darwin Discovery Limited |
9-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,9-dihydropurin-6-one derivatives as pde7 inhibitors
|
|
EP1214060A2
(en)
|
1999-09-10 |
2002-06-19 |
Novo Nordisk A/S |
Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
|
|
AU6985300A
(en)
|
1999-09-10 |
2001-04-17 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (ptpases)
|
|
WO2001032610A1
(en)
|
1999-10-29 |
2001-05-10 |
Kaken Pharmaceutical Co., Ltd. |
Urea derivative, process for producing the same, and medicine containing the urea derivative
|
|
AR030537A1
(es)
|
1999-11-05 |
2003-08-27 |
Abbott Lab |
Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos
|
|
US20020049223A1
(en)
|
1999-11-05 |
2002-04-25 |
Elmore Steven W. |
Quinoline and naphthyridine carboxylic acid antibacterials
|
|
WO2002012189A1
(en)
|
2000-08-09 |
2002-02-14 |
Mitsubishi Pharma Corporation |
Fused bicyclic amide compounds and medicinal use thereof
|
|
AU2001286191A1
(en)
|
2000-09-12 |
2002-03-26 |
Sankyo Company, Limited |
Quinolizine derivatives
|
|
JP2002179678A
(ja)
|
2000-09-12 |
2002-06-26 |
Sankyo Co Ltd |
キノリジン化合物
|
|
DOP2002000386A
(es)
|
2001-05-30 |
2002-12-15 |
Warner Lambert Co |
Agentes antibacterianos
|
|
WO2002102387A1
(en)
|
2001-06-18 |
2002-12-27 |
H. Lundbeck A/S |
Treatment of neuropathic pain
|
|
WO2002102793A2
(en)
|
2001-06-19 |
2002-12-27 |
Warner-Lambert Company Llc |
Quinazolinediones as antibacterial agents
|
|
WO2003006455A1
(en)
|
2001-07-11 |
2003-01-23 |
Eli Lilly And Company |
Pharmaceutical compounds with serotonin receptor activity
|
|
US20040180883A1
(en)
|
2001-07-11 |
2004-09-16 |
Jeremy Gilmore |
Pharmaceutical compounds with serotonin receptor activity
|
|
JP5039268B2
(ja)
|
2001-10-26 |
2012-10-03 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
ベンゾイミダゾールおよび類縁体および蛋白キナーゼ阻害剤としてのその使用
|
|
JP2003261566A
(ja)
|
2002-03-11 |
2003-09-19 |
Sankyo Co Ltd |
キノリジンを含有する医薬
|
|
TW200306783A
(en)
|
2002-04-29 |
2003-12-01 |
Fmc Corp |
Pesticidal heterocycles
|
|
US7358269B2
(en)
|
2002-05-21 |
2008-04-15 |
Allergan, Inc. |
2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one
|
|
US7323485B2
(en)
|
2002-05-21 |
2008-01-29 |
Allergan, Inc. |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
|
|
US7276522B2
(en)
|
2002-05-21 |
2007-10-02 |
Allergan, Inc. |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
|
|
US7091232B2
(en)
|
2002-05-21 |
2006-08-15 |
Allergan, Inc. |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
|
|
SE0202134D0
(sv)
|
2002-07-08 |
2002-07-08 |
Astrazeneca Ab |
Therapeutic agents
|
|
WO2004035812A2
(en)
|
2002-10-16 |
2004-04-29 |
Isis Innovation Limited |
Asparaginyl hydroxylases and modulators thereof
|
|
KR100678800B1
(ko)
|
2002-11-21 |
2007-02-05 |
화이자 프로덕츠 인코포레이티드 |
3-아미노-피페리딘 유도체 및 그의 제조 방법
|
|
EP1587482A4
(en)
|
2003-01-31 |
2010-08-25 |
Technion Res & Dev Foundation |
INFLAMMATORY COMPOSITIONS AND ITS USES
|
|
EP2527326B1
(en)
|
2003-03-07 |
2014-10-08 |
Santen Pharmaceutical Co., Ltd |
Novel compounds having 4-pyridylalkylthio group as substituent
|
|
JP2004269449A
(ja)
|
2003-03-11 |
2004-09-30 |
Ishihara Sangyo Kaisha Ltd |
ベンズアミド誘導体、それらの製造方法及びそれらを含有する有害生物防除剤
|
|
US20070154534A1
(en)
|
2003-03-12 |
2007-07-05 |
Sheitman Brian B |
Use of secretin in the treatment of schizophrenia
|
|
US7205318B2
(en)
|
2003-03-18 |
2007-04-17 |
Bristol-Myers Squibb Company |
Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors
|
|
JP2006522109A
(ja)
|
2003-03-31 |
2006-09-28 |
大正製薬株式会社 |
新規なキナゾリン誘導体及びそれらの使用に関連する治療方法
|
|
JP2005145859A
(ja)
|
2003-11-13 |
2005-06-09 |
Nippon Steel Chem Co Ltd |
脱水素化方法及び芳香族複素環化合物の製造方法
|
|
DE10360793A1
(de)
|
2003-12-23 |
2005-07-28 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
JP2007529422A
(ja)
|
2004-01-29 |
2007-10-25 |
エリクシアー ファーマシューティカルズ， インコーポレイテッド |
抗ウイルス治療
|
|
DE102004004974A1
(de)
|
2004-01-31 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Thieno-Iminosäure-Derivate als Inhibitoren von Matrix-Metalloproteinasen
|
|
KR100553398B1
(ko)
|
2004-03-12 |
2006-02-16 |
한미약품 주식회사 |
티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
|
|
RU2007107177A
(ru)
|
2004-07-28 |
2008-09-10 |
Айрм Ллк (Bm) |
Соединения и композиции, как модуляторы ядерных рецепторов стероидных гормонов
|
|
SE0401971D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidne derivatives
|
|
SE0401970D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Novel compounds
|
|
EP1634873A1
(en)
|
2004-08-27 |
2006-03-15 |
Laboratorios Del Dr. Esteve, S.A. |
Sigma receptor inhibitors
|
|
FR2875230A1
(fr)
|
2004-09-13 |
2006-03-17 |
Sanofi Aventis Sa |
Derives de pyrazole condense, leur preparation et leur application en therapeutique
|
|
JP2006117568A
(ja)
|
2004-10-20 |
2006-05-11 |
Mitsubishi Pharma Corp |
チオフェン環を有する新規アミド誘導体及びその医薬としての用途
|
|
WO2006053274A2
(en)
|
2004-11-15 |
2006-05-18 |
Bristol-Myers Squibb Company |
2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
|
|
EP1856126A2
(en)
|
2005-02-17 |
2007-11-21 |
Wyeth a Corporation of the State of Delaware |
Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
|
|
CN101203512A
(zh)
|
2005-04-22 |
2008-06-18 |
第一三共株式会社 |
杂环化合物
|
|
EP1896515A4
(en)
|
2005-06-27 |
2010-03-10 |
Du Pont |
ELECTRICALLY CONDUCTIVE POLYMER COMPOSITIONS
|
|
WO2007001939A1
(en)
|
2005-06-27 |
2007-01-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities
|
|
JP2009505948A
(ja)
|
2005-07-11 |
2009-02-12 |
デブジェン エヌブイ |
キナーゼ阻害剤としてのアミド誘導体
|
|
US8846742B2
(en)
|
2006-02-14 |
2014-09-30 |
The Trustees Of Columbia University In The City Of New York |
Neuronal pain pathway modulators
|
|
AU2007222069A1
(en)
|
2006-02-21 |
2007-09-13 |
Ampla Pharmaceuticals Inc. |
CB1 antagonists and inverse agonists
|
|
EP1829869A1
(en)
|
2006-03-02 |
2007-09-05 |
Laboratorios Del Dr. Esteve, S.A. |
4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
|
|
JPWO2007126041A1
(ja)
|
2006-04-28 |
2009-09-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ベンゾイソオキサゾール化合物
|
|
EP2069326B1
(en)
|
2006-10-04 |
2015-03-18 |
Merck Sharp & Dohme Corp. |
Bicyclic and tricyclic derivatives as thrombin receptor antagonists
|
|
US7960569B2
(en)
|
2006-10-17 |
2011-06-14 |
Bristol-Myers Squibb Company |
Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
WO2008058342A1
(en)
|
2006-11-15 |
2008-05-22 |
Genetic Technologies Limited |
Compounds, compositions and methods for controlling invertebrate pests
|
|
WO2009008906A2
(en)
|
2007-02-06 |
2009-01-15 |
The Trustees Of The University Of Pennsylvania |
Therapeutic compounds for blocking dna synthesis of pox viruses
|
|
US7598417B2
(en)
|
2007-04-12 |
2009-10-06 |
Allergan, Inc. |
Substituted fluoroethyl ureas as alpha 2 adrenergic agents
|
|
EP1982987A1
(en)
|
2007-04-16 |
2008-10-22 |
Laboratorios del Dr. Esteve S.A. |
Spiro-pyrano-pyrazole derivatives
|
|
EP1982714A1
(en)
|
2007-04-16 |
2008-10-22 |
Laboratorios del Dr. Esteve S.A. |
Pyrano-pyrazole-amines
|
|
EP2020414A1
(en)
|
2007-06-20 |
2009-02-04 |
Laboratorios del Dr. Esteve S.A. |
spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis
|
|
US8338623B2
(en)
|
2007-07-09 |
2012-12-25 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
|
ES2469824T3
(es)
|
2007-11-21 |
2014-06-20 |
Janssen Pharmaceutica N.V. |
Espiropiperidinas para su uso como inhibidores de la triptasa
|
|
US7973051B2
(en)
|
2007-11-30 |
2011-07-05 |
Hoffman-La Roche Inc. |
Aminothiazoles as FBPase inhibitors for diabetes
|
|
JPWO2009072621A1
(ja)
|
2007-12-07 |
2011-04-28 |
日産化学工業株式会社 |
置換ジヒドロアゾール化合物及び有害生物防除剤
|
|
WO2009085256A1
(en)
|
2007-12-27 |
2009-07-09 |
Panacos Pharmaceuticals, Inc. |
Anti-hiv compounds
|
|
CN101759710B
(zh)
|
2008-10-06 |
2011-10-05 |
山东轩竹医药科技有限公司 |
含有取代的氮杂环的头孢菌素衍生物
|
|
US9776963B2
(en)
|
2008-11-10 |
2017-10-03 |
The Trustees Of The University Of Pennsylvania |
Small molecule CD4 mimetics and uses thereof
|
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
|
WO2011036889A1
(ja)
|
2009-09-25 |
2011-03-31 |
武田薬品工業株式会社 |
複素環化合物
|
|
ES2436241T3
(es)
|
2009-11-16 |
2013-12-27 |
Eli Lilly And Company |
Compuestos de espiropiperidina como antagonistas de receptor oral-1
|
|
UA107943C2
(xx)
|
2009-11-16 |
2015-03-10 |
Lilly Co Eli |
Сполуки спіропіперидину як антагоністи рецептора orl-1
|
|
CN106883246B
(zh)
|
2009-12-04 |
2020-05-29 |
桑诺维恩药品公司 |
多环化合物及其使用方法
|
|
KR101778320B1
(ko)
|
2009-12-28 |
2017-09-13 |
잇반샤단호우징 화루마바레프로제쿠토 시엥기코우 |
1,3,4-옥사디아졸-2-카르복사미드 화합물
|
|
EP2377850A1
(en)
|
2010-03-30 |
2011-10-19 |
Pharmeste S.r.l. |
TRPV1 vanilloid receptor antagonists with a bicyclic portion
|
|
US8895608B2
(en)
|
2010-04-23 |
2014-11-25 |
Kineta, Inc. |
Sulfonamide anti-viral compounds
|
|
US9132136B2
(en)
|
2010-08-02 |
2015-09-15 |
Hoffmann-La Roche Inc. |
Pharmaceutical combination
|
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
JP5715713B2
(ja)
|
2011-03-10 |
2015-05-13 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
可溶性グアニル酸シクラーゼ活性化因子
|
|
CN102731574B
(zh)
|
2011-03-30 |
2016-03-02 |
中国人民解放军军事医学科学院毒物药物研究所 |
噻吩并吡啶类α-胺基苄基膦酸酯、其制备方法及用途
|
|
WO2013010453A1
(en)
|
2011-07-15 |
2013-01-24 |
Abbott Laboratories |
Chemoking receptor antagonists
|
|
JP6333382B2
(ja)
|
2014-07-23 |
2018-05-30 |
シャープ株式会社 |
表示装置およびその駆動方法
|
|
IL268694B2
(en)
*
|
2017-02-16 |
2023-10-01 |
Sunovion Pharmaceuticals Inc |
Treatment of schizophrenia
|
|
JP2021513972A
(ja)
|
2018-02-16 |
2021-06-03 |
サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
社会的機能障害の治療方法
|
|
EA202091945A1
(ru)
|
2018-02-16 |
2021-01-18 |
Суновион Фармасьютикалз Инк. |
Соли, кристаллические формы и способы их получения
|
|
CN118576586A
(zh)
|
2018-12-06 |
2024-09-03 |
住友制药美国公司 |
治疗神经和精神疾病的方法
|
|
CN115734785A
(zh)
|
2020-04-14 |
2023-03-03 |
桑诺维恩药品公司 |
(S)-(4,5-二氢-7H-噻吩并[2,3-c]吡喃-7-基)-N-甲基甲胺用于治疗神经和精神方面的病症
|
|
US12492213B2
(en)
|
2020-09-16 |
2025-12-09 |
Assia Chemical Industries Ltd. |
Solid state forms of sep-363856 and process for preparation thereof
|